Cargando…
Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China
BACKGROUND: The clinical characteristics and disease course in COVID-19 patients with pre-existing decompensated cirrhosis has not been described so far. METHODS: In this case series, we report three patients with confirmed COVID-19 and pre-existing decompensated cirrhosis from three hospitals in Hu...
Autores principales: | Qi, Xiaolong, Wang, Jitao, Li, Xinyu, Wang, Zhengyan, Liu, Yanna, Yang, Hua, Li, Xiaodan, Shi, Jindong, Xiang, Huihua, Liu, Tao, Kawada, Norifumi, Maruyama, Hitoshi, Jiang, Zicheng, Wang, Fengmei, Takehara, Tetsuo, Rockey, Don C., Sarin, Shiv Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242176/ https://www.ncbi.nlm.nih.gov/pubmed/32440857 http://dx.doi.org/10.1007/s12072-020-10051-z |
Ejemplares similares
-
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study
por: Qi, Xiaolong, et al.
Publicado: (2021) -
Clostridioides difficile Induced Rhabdomyolysis
Associated With Decompensated Cirrhosis
por: Dungan, William, et al.
Publicado: (2022) -
Spontaneous cryptococcal peritonitis with fungemia in patients with decompensated cirrhosis: Report of two cases
por: Bal, Chinmaya Kumar, et al.
Publicado: (2014) -
Evaluation of the Prognostic Value of Existing Scoring Systems for Nosocomial Infection in Patients with Decompensated Liver Cirrhosis
por: Zhao, Xu, et al.
Publicado: (2023) -
Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis
por: Sakamori, Ryotaro, et al.
Publicado: (2021)